MYC and Miyoshi myopathy: General higher mutation rate than MGUS [57,90,91,92,93]; genomic changes, environmental factors, and mutational burden [3,66,99]; IGH-MYC [100]; complex rearrangements with lower cancer cell ratio than MM [3]; chr(8p) deletions [46]